Chemours CO CC
We take great care to ensure that the data presented and summarized in this overview for Chemours Co is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CC
View all-
Vanguard Group Inc Valley Forge, PA17.7MShares$220 Million0.0% of portfolio
-
Black Rock Inc. New York, NY16.3MShares$202 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny7.41MShares$92.1 Million0.04% of portfolio
-
State Street Corp Boston, MA6.11MShares$76 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY5.52MShares$68.6 Million0.01% of portfolio
-
Ubs Group Ag4.74MShares$58.9 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN4.22MShares$52.4 Million0.01% of portfolio
-
Appian Way Asset Management LP New York, NY3.81MShares$47.4 Million11.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$43.3 Million0.0% of portfolio
-
Scopia Capital Management LP New York, NY3.36MShares$41.7 Million4.69% of portfolio
Latest Institutional Activity in CC
Top Purchases
Top Sells
About CC
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Insider Transactions at CC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 12
2025
|
David Will Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,374
-8.61%
|
$28,488
$12.42 P/Share
|
Aug 08
2025
|
Denise Dignam President & CEO |
BUY
Open market or private purchase
|
Direct |
4,068
+2.08%
|
$48,816
$12.06 P/Share
|
Aug 06
2025
|
Shane Hostetter Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,021
-5.02%
|
$36,252
$12.0 P/Share
|
Aug 01
2025
|
Joseph T. Martinko Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-2.05%
|
$7,139
$11.5 P/Share
|
Aug 01
2025
|
Denise Dignam President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-0.25%
|
$5,126
$11.5 P/Share
|
Aug 01
2025
|
Calderon Gerardo Familiar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
923
-2.31%
|
$10,153
$11.5 P/Share
|
Aug 01
2025
|
Kristine M Wellman SVP, GC & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-0.72%
|
$4,213
$11.5 P/Share
|
Jun 03
2025
|
Damian Gumpel Officer |
BUY
Open market or private purchase
|
Direct |
7,822
+5.61%
|
$70,398
$9.95 P/Share
|
Jun 02
2025
|
Damian Gumpel Officer |
BUY
Open market or private purchase
|
Direct |
13,400
+9.76%
|
$120,600
$9.22 P/Share
|
May 19
2025
|
Shane Hostetter Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,450
+6.94%
|
$48,950
$11.28 P/Share
|
Apr 22
2025
|
Pamela Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+36.46%
|
-
|
Apr 22
2025
|
Dawn L Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+12.62%
|
-
|
Apr 22
2025
|
Alister Cowan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+28.23%
|
-
|
Apr 22
2025
|
Erin N Kane Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+17.78%
|
-
|
Apr 22
2025
|
Mary B Cranston Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+12.3%
|
-
|
Apr 22
2025
|
Leslie M Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+45.36%
|
-
|
Apr 22
2025
|
Joseph Daniel Kava Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+45.36%
|
-
|
Apr 22
2025
|
Livingston Satterthwaite Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+37.97%
|
-
|
Apr 22
2025
|
Sean D Keohane Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+18.08%
|
-
|
Apr 22
2025
|
Courtney Mather Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,096
+50.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 478K shares |
---|---|
Open market or private purchase | 29.7K shares |
Payment of exercise price or tax liability | 19.8K shares |
---|---|
Open market or private sale | 7.5K shares |